Navigation Links
AVT Develops Biometrically Secure Medicine Storage and Retrieval System for Medbox RX
Date:10/25/2012

CORONA, Calif., Oct. 16, 2012 /PRNewswire/ -- AVT, Inc. (Ticker: AVTC) (www.autoretail.com) announced that they have developed a new line of self-service medicine storage and retrieval systems for deployment in pharmacies nationwide. The systems have been developed for Medbox RX, a leader in storage and dispensing solutions for the pharmaceutical and healthcare industries.

The Medbox RX Medication Storage and Retrieval System, called the "Lockbox Rx," is a patented system that stores medicines in secure lockers, controls employee access based on customizable parameters, and allow patients to pick up their prescriptions in an automated, self-service manner.

The Lockbox Rx provides pharmacists with an innovative and cost-effective method of improving efficiencies, and allows customers to "skip the lines" and pick up their prescriptions quickly and at their convenience.

The system is designed so that a pharmacist can, upon request, place a patient's prescription refill in the storage lockbox for later retrieval. This unburdens the pharmacy staff and gives the consumer added flexibility in when and how they will pick up their medicine.

To retrieve their medicine, the consumer places their finger on the system's scanner and a biometric recognition scan will verify their identity and open their lockbox. The system also keeps track of all transactions, including when prescriptions are placed into the lockbox, and when they are retrieved.

"This system is good for the pharmacist and good for the consumer," stated Shannon Illingworth, Founder and Chairman of AVT, Inc. "In today's competitive environment, those pharmacies that can reduce costs and increase customer satisfaction will see improvements in margins and customer loyalty."

For more information on AVT, please contact the Investor Relations Department at 877.424.3663 or visit AVT's website at

SOURCE AVT, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. BGI Tech develops whole exome sequencing analysis of FFPE DNA samples to boost biomedicine
2. IU chemist develops new synthesis of most useful, yet expensive, antimalarial drug
3. MMV develops framework to assess risk of resistance for antimalarial compounds
4. US-Russian collaboration develops new method for sequencing dark matter of life from a single cell
5. University of Illinois professor develops tool that helps dietitians deliver info clients need and can understand
6. Pitt develops biodegradable artery graft to enhance bypass surgeries
7. MindSpec develops Autism Quiz app
8. Geneticist develops tool to identify genes important in disease, tailoring individual treatment
9. Pod corn develops leaves in the inflorescences
10. Genetic research develops tools for studying diseases, improving regenerative treatment
11. Diabetes Research Institute develops oxygen-generating biomaterial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... different types of cell, including sperm, bacteria and ... flagella. These protrusions, about one-hundredth of a millimetre ... through fluid. Similar, shorter structures called cilia are ... they perform roles such as moving liquids over ... remarkably versatile: they transport mucus and expel pathogens ...
(Date:7/28/2014)... of two additional coral communities showing signs of damage from ... the 2010 spill in the Gulf of Mexico. The discovery ... of biology at Penn State University. A paper describing this ... the Gulf of Mexico will be published during the last ... the journal Proceedings of the National Academy of Sciences ...
(Date:7/28/2014)... Millions of people in the United States have a ... It can be painful and may even require surgery ... skeletal muscle wasting and, in turn, limb amputation. , ... Houston (UTHealth) Medical School, scientists tested a non-surgical preventative ... it was associated with increased blood circulation. Their ...
Breaking Biology News(10 mins):Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3Impact of Deepwater Horizon oil spill on coral is deeper and broader than predicted 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... A Senior Design team at Stevens Institute of Technology ... often arise during thoracic surgeries. Five undergraduate Biomedical Engineering ... issues of existing catheter design and introduces a potentially ... 21, the efforts of the Stevens Innovative Fluid Extraction ...
... Los Angeles, Calif., May 22, 2011Some men of African ... cancer, according to research conducted at the Keck School of ... genome-wide association study, published in the journal Nature Genetics ... prostate cancer in men of African descent, who tend to ...
... automated microfluidic cell culture platform to monitor the growth, ... (HSCs) at the single cell level. This ... culture conditions simultaneously and to gain new insights on ... "The ability to perform massively parallel cultures of single ...
Cached Biology News:Stevens thoracic catheter senior design team takes 1st place at regional ISPE competition 2Stevens thoracic catheter senior design team takes 1st place at regional ISPE competition 3USC research determines apparent genetic link to prostate cancer in African-American men 2UBC-led team develops platform to monitor hematopoietic stem cells 2
(Date:7/29/2014)... Calif. , July 29, 2014 /PRNewswire-iReach/ -- ... agreement with FORMA Therapeutics, Inc., to provide access ... proprietary fragment-based lead discovery platform for novel small ... excited about the opportunity to work with FORMA ... of epigenetics and protein homeostasis. FORMA Therapeutics, decision ...
(Date:7/29/2014)... & Rockville, MD (PRWEB) July 29, 2014 ... Inc. (ITI), a vaccine pioneer in the biotechnology ... services firm Newport Coast Securities, Inc. to explore ... is commercializing LAMP-vax technology, a breakthrough vaccine platform ... and immunotherapy market. The company exclusively licensed the ...
(Date:7/29/2014)... WA (PRWEB) July 29, 2014 ... IRB services, has been awarded accreditation by the ... for its Lean Six Sigma Deployment Program. ... waste and improve performance. , Quorum’s Lean Six ... the Accredited Deployment Program designation. The designation is ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The prestigious ... of Congress was recently awarded to Juliana Hillis and ... MA, for their project, “From an Egg, Everything: America’s ... 3,000 final entries for the National History Day program ... 300 historians and educators in Washington, D.C. , The ...
Breaking Biology Technology:Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3
... A ... into specific T cell lineages to the activity of a single gene encoding a transcription ... the development of blood cells lineages. , ... (PRWeb UK) July 1, 2010 -- A research team in Japan has linked ...
... , WALTHAM, Mass. , July 1 ... multi-year collaborative agreement with Roche to apply X-Chem,s proprietary ... several of Roche,s high-value therapeutic targets. As part of ... research payments, success-based discovery milestones, and technology access fees. ...
... CLEVELAND , June 30 RSB Spine, LLC, a medical ... of degenerative disc disease, today announced a 50% sales increase for the ... sequentially. Additionally, the company reported record sales for the month of June. ... RSB Spine Chief Executive ...
Cached Biology Technology:The Last Checkpoint to T Cell Fate 2X-Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement 2